MetLife Investment Management’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Hold |
4,907
| – | – | ﹤0.01% | 1837 |
|
|
2025
Q1 | $368K | Sell |
4,907
-84
| -2% | -$6.3K | ﹤0.01% | 1870 |
|
|
2024
Q4 | $510K | Hold |
4,991
| – | – | ﹤0.01% | 1787 |
|
|
2024
Q3 | $526K | Hold |
4,991
| – | – | ﹤0.01% | 1755 |
|
|
2024
Q2 | $465K | Buy |
4,991
+432
| +9% | +$40.2K | ﹤0.01% | 1755 |
|
|
2024
Q1 | $594K | Hold |
4,559
| – | – | ﹤0.01% | 1583 |
|
|
2023
Q4 | $517K | Hold |
4,559
| – | – | ﹤0.01% | 1665 |
|
|
2023
Q3 | $374K | Hold |
4,559
| – | – | ﹤0.01% | 1805 |
|
|
2023
Q2 | $428K | Hold |
4,559
| – | – | ﹤0.01% | 1802 |
|
|
2023
Q1 | $310K | Buy |
4,559
+152
| +3% | +$10.3K | ﹤0.01% | 1936 |
|
|
2022
Q4 | $313K | Sell |
4,407
-565
| -11% | -$40.2K | ﹤0.01% | 1952 |
|
|
2022
Q3 | $309K | Sell |
4,972
-89
| -2% | -$5.53K | ﹤0.01% | 1998 |
|
|
2022
Q2 | $338K | Hold |
5,061
| – | – | ﹤0.01% | 1938 |
|
|
2022
Q1 | $364K | Buy |
5,061
+1,588
| +46% | +$114K | ﹤0.01% | 1975 |
|
|
2021
Q4 | $333K | Hold |
3,473
| – | – | ﹤0.01% | 1745 |
|
|
2021
Q3 | $170K | Hold |
3,473
| – | – | ﹤0.01% | 2192 |
|
|
2021
Q2 | $175K | Buy |
+3,473
| New | +$175K | ﹤0.01% | 2241 |
|
|
2019
Q4 | – | Sell |
-4,247
| Closed | -$137K | – | 2305 |
|
|
2019
Q3 | $137K | Buy |
+4,247
| New | +$137K | ﹤0.01% | 2157 |
|
|
2018
Q4 | – | Sell |
-4,469
| Closed | -$141K | – | 2572 |
|
|
2018
Q3 | $141K | Hold |
4,469
| – | – | ﹤0.01% | 2279 |
|
|
2018
Q2 | $168K | Buy |
+4,469
| New | +$168K | ﹤0.01% | 1998 |
|